Skip to main content

Twirla News

Estrogen-Linked Thrombotic Biomarkers Drop After Cessation of Combo Pill

TUESDAY, Nov. 14, 2023 – Cessation of combined hormonal contraceptives (CHC) is associated with a rapid decline in estrogen-related thrombotic biomarkers, according to a study published online Nov....

Blood Clot Risk From Contraceptive Pills Ends Soon After Women Stop Taking Them

FRIDAY, Nov. 10, 2023 – Women and their doctors have long known that taking birth control pills can elevate the risk for a blood clot. Now, some good news: That added risk will disappear within a...

Combo of Certain Birth Control Pills, Painkillers Could Raise Women's Clot Risk

FRIDAY, Sept. 8, 2023 – It's well known that certain forms of birth control carry a small risk of blood clots. Now a large new study suggests that some common painkillers can magnify that risk. The...

FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch

PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) – Agile Therapeutics, Inc., (Nasdaq: AGRX) (Agile or the Company), a forward-thinking women’s healthcare company, today announced that the U.S. Food a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Contraception, Birth Control

Twirla patient information at Drugs.com